Albemarle Corporation (ALB) Stock Performance: Recent Trends and Earnings Estimates
ByAinvest
Monday, Aug 4, 2025 10:11 am ET1min read
ALB--
The Zacks Rank for Albemarle is #4 (Sell), indicating that the company may underperform the broader market in the near term. This ranking is based on recent changes in the consensus earnings estimate and other factors related to earnings estimates. The Zacks Rank system is a proprietary tool that effectively harnesses the power of earnings estimate revisions to predict a stock's near-term price performance [1].
Albemarle reported revenues of $1.33 billion in the last reported quarter, surpassing the Zacks Consensus Estimate by 6.98%. This compares to year-ago revenues of $1.43 billion. The company has topped consensus revenue estimates just once over the last four quarters [2].
Looking ahead, the consensus EPS estimate for the coming quarter is -$0.60 on $1.26 billion in revenues, and for the current fiscal year, it is -$2.24 on $4.85 billion in revenues. The Zacks Industry Rank for the Chemical - Diversified sector, to which Albemarle belongs, is currently in the bottom 5% of the 250 plus Zacks industries [2].
The sustainability of Albemarle's immediate price movement will depend on management's commentary on the earnings call. Investors should keep an eye on the company's earnings outlook and how the estimates for the coming quarters and the current fiscal year change in the days ahead.
References:
[1] https://finance.yahoo.com/news/trending-stock-albemarle-corporation-alb-130003270.html
[2] https://finance.yahoo.com/news/albemarle-alb-q2-earnings-revenues-213001925.html
Albemarle Corporation (ALB) stock has returned +1% over the past month, compared to the Zacks S&P 500 composite's +0.6% change. The company is expected to post a loss of $0.68 per share for the current quarter, a year-over-year change of +56.1%. However, the consensus earnings estimate for the current fiscal year is -$2.22, a year-over-year change of +5.1%. The Zacks Rank for Albemarle is #4 (Sell), based on the recent change in the consensus estimate and other factors related to earnings estimates.
Albemarle Corporation (ALB) has seen its stock return +1% over the past month, slightly outperforming the Zacks S&P 500 composite's +0.6% change. The specialty chemicals company is expected to post a loss of $0.68 per share for the current quarter, representing a year-over-year change of +56.1% [1]. However, the consensus earnings estimate for the current fiscal year is -$2.22, a year-over-year change of +5.1%.The Zacks Rank for Albemarle is #4 (Sell), indicating that the company may underperform the broader market in the near term. This ranking is based on recent changes in the consensus earnings estimate and other factors related to earnings estimates. The Zacks Rank system is a proprietary tool that effectively harnesses the power of earnings estimate revisions to predict a stock's near-term price performance [1].
Albemarle reported revenues of $1.33 billion in the last reported quarter, surpassing the Zacks Consensus Estimate by 6.98%. This compares to year-ago revenues of $1.43 billion. The company has topped consensus revenue estimates just once over the last four quarters [2].
Looking ahead, the consensus EPS estimate for the coming quarter is -$0.60 on $1.26 billion in revenues, and for the current fiscal year, it is -$2.24 on $4.85 billion in revenues. The Zacks Industry Rank for the Chemical - Diversified sector, to which Albemarle belongs, is currently in the bottom 5% of the 250 plus Zacks industries [2].
The sustainability of Albemarle's immediate price movement will depend on management's commentary on the earnings call. Investors should keep an eye on the company's earnings outlook and how the estimates for the coming quarters and the current fiscal year change in the days ahead.
References:
[1] https://finance.yahoo.com/news/trending-stock-albemarle-corporation-alb-130003270.html
[2] https://finance.yahoo.com/news/albemarle-alb-q2-earnings-revenues-213001925.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet